García-García A, Korn C, García-Fernández M, et al. Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes. Blood. 2019;133(3):224-236.

Publikováno v: Blood [Blood] 2020 Dec 17; Vol. 136 (25), pp. 2965.

授業における規律指導と自己規律の形成に関する一考察 : コルン（Korn, C.）によるDisziplinの問題史的考察を手がかりに

Autor: Hayakawa, Tomohiro

The purpose of this paper is to clarify the significance of the teaching of discipline for the formation of self-discipline. This is done by looking at recent teaching trends for discipline, namely the historical study of the German word Disziplin by

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6d023552965ea1794356f89cec5ad534
http://ir.lib.hiroshima-u.ac.jp/00044809

Mean encounter times for cell adhesion in hydrodynamic flow: analytical progress by dimensional reduction

Autor: Korn, C. B., Schwarz, U. S.

Publikováno v: EPL 83:28007 (2008)

For a cell moving in hydrodynamic flow above a wall, translational and rotational degrees of freedom are coupled by the Stokes equation. In addition, there is a close coupling of convection and diffusion due to the position-dependent mobility. These

Externí odkaz: http://arxiv.org/abs/0806.4444

Mean first passage times for bond formation for a Brownian particle in linear shear flow above a wall

Autor: Korn, C., Schwarz, U. S.

Publikováno v: J. Chem. Phys. 126, 095103 (2007)

Motivated by cell adhesion in hydrodynamic flow, here we study bond formation between a spherical Brownian particle in linear shear flow carrying receptors for ligands covering the boundary wall. We derive the appropriate Langevin equation which incl

Externí odkaz: http://arxiv.org/abs/cond-mat/0610302

RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.

Autor: Grether U; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Foxton RH; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Gruener S; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Korn C; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Kimbara A; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Osterwald A; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Zirwes E; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Uhles S; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Thoele J; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Colé N; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Rogers-Evans M; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Röver S; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Nettekoven M; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Martin RE; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Adam JM; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Fingerle J; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Bissantz C; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Guba W; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Alker A; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Szczesniak AM; Departments of Pharmacology, Anesthesia, Ophthalmology and Visual Sciences, Dalhousie University, Halifax, NS, Canada., Porter RF; Departments of Pharmacology, Anesthesia, Ophthalmology and Visual Sciences, Dalhousie University, Halifax, NS, Canada., Toguri TJ; Departments of Pharmacology, Anesthesia, Ophthalmology and Visual Sciences, Dalhousie University, Halifax, NS, Canada., Revelant F; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Poirier A; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Perret C; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Winther L; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Caruso A; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Fezza F; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy., Maccarrone M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.; European Center for Brain Research (CERC), Santa Lucia Foundation IRCCS, Rome, Italy., Kelly MEM; Departments of Pharmacology, Anesthesia, Ophthalmology and Visual Sciences, Dalhousie University, Halifax, NS, Canada., Fauser S; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Ullmer C; F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2024 Jul 12; Vol. 15, pp. 1426446. Date of Electronic Publication: 2024 Jul 12 (Print Publication: 2024).